-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi's Cablivi Gets FDA's Approval To Treat Acquired Thrombotic Thrombocytopenic Purpura For Patients 12 Years, Older

Benzinga·01/05/2026 19:20:27
Listen to the news